NK

Neil Kumar

DELAYED 1 MONTH

Director, Chief Executive Officer

BridgeBio Pharma, Inc.

Filings

5

Companies

1

Latest

Jun 4, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

70
BBIOCLUSTER 3

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Sale

$2.7M

40,000 sh

Jun 8 10:01 PM

Jun 5, 2026

70
BBIOCLUSTER 3

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Sale

$2.7M

40,000 sh

Jun 8 10:01 PM

Jun 4, 2026

72
BBIOCLUSTER 4

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Sale

$1.8M

26,103 sh

May 26 8:54 PM

May 21, 2026

—

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Option Exercise

—

71,215 sh

May 19 8:27 PM

May 16, 2026

66
BBIOCLUSTER 2

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Sale

$2.7M

40,000 sh

May 11 9:15 PM

May 8, 2026

66
BBIOCLUSTER 2

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Sale

$2.7M

40,000 sh

May 11 9:15 PM

May 7, 2026

70
BBIOCLUSTER 3

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Sale

$2.8M

40,000 sh

Mar 16 10:05 PM

Mar 13, 2026

70
BBIOCLUSTER 3

BridgeBio Pharma, Inc.

Neil Kumar

Director, Chief Executive Officer

Sale

$2.7M

40,000 sh

Mar 16 10:05 PM

Mar 12, 2026